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INTRODUCTION
Cell–matrix interactions regulate various cellular processes including survival, cell
growth and diﬀerentiation (Boudreau and Bissel, 1998; Giancotti, 2000). Integrins are
the major surface receptors that mediate such interactions (Hynes, 1992). They are
composed of a and b chain heterocomplexes. Engagement of integrin receptors and
their clustering leads to the formation of ‘focal adhesions’ where integrins link to
intracellular cytoskeletal complexes and bundles of actin ﬁlaments. However, these
complexes not only serve to connect the cytoskeleton to the matrix but also serve as
a framework for the association of signalling proteins that regulate signal transduc-
tion pathways leading to integrin-induced changes in cell behaviour (Burridge et al.,
1988). Focal adhesions contain multiple proteins such as vinculin, talin and tensin.
Other proteins localized in focal adhesions include kinases, phospholipases and prote-
ases. The actin cytoskeleton needs to be dynamic for cell shape changes in cell
contacts and cell motility. The deregulation of cytoskeletal function contributes to
malignant transformation. In normal cells, the cytoskeleton is very stable and there is
little movement of cells. In cells that have become cancerous, the cytoskeleton is
disrupted in such a way as to increase cell motility.
Paxillin is a focal adhesion-associated adaptor protein that plays a key role in cell
spreading and motility (Schaller, 2001). This protein was originally identiﬁed as a
substrate for the non-receptor tyrosine kinase oncogene pp60v-src in Rous sarcoma
virus-transformed ﬁbroblasts (Glenney and Zokas, 1989). Paxillin is ubiquitously
expressed, albeit in variable amounts, with low levels in platelets and neuronal cells.
It is highly conserved among various species.
Although the role of paxillin as a regulatory protein in focal adhesion dynamics
and cell movement, has been well studied in cultured cells, its speciﬁc role in signalling
in the complex organization of individual tissues has not yet been established. The
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aim of this work was to evaluate the expression levels of paxillin and other focal
adhesion-associated proteins (talin, vinculin, a-actinin) in mammary tumour tissues
from cats and dogs.
MATERIALS ANDMETHODS
T issue preparation
Mammary tumour and normal tissues were obtained from the dogs and cats under-
going surgical resection at the Department of Veterinary Clinical Sciences of the
University of Napoli Federico II (Italy). Tissue samples were divided into two parts:
the ﬁrst was used for routine histological diagnosis using ﬁxation in formalin. The
second part, consisting of fresh material, was used for analysis of protein proﬁles
using the Western blotting technique. Tissue samples were perfused thoroughly with
0.9% NaCl and homogenized using an Ultraturrax L-407 at 4°C with 5 ml of buﬀer
(10 mmol/L Tris-HCl, pH 7.4, 10 mmol/L EDTA, 5 mmol/L dithiothreitol, 10%
glycerol, 0.1 U trypsin/ml aprotinin, 10 mg/ml leupeptin and 4 mmol/L pepstatin) per
1.5 g of tissue. Homogenates were divided into small aliquots and stored at −80°C
until use. The protein content of each sample was determined by Bio-Rad DC pro-
tein assay.
Electrophoresis and Western blot
Samples containing equal amounts of protein were run on an electrophoresis appara-
tus using 7.5% SDS/polyacrylamide gels. Following electrophoresis, the samples were
transferred onto nitrocellulose ﬁlter. The blots, after blocking (for 1 h at 42°C in
Tris/NaCl/Pi containing 5% BSA) and washing, were incubated for 2 h with either
anti-paxillin IgG or anti-vinculin or anti a-actinin or anti-talin IgG. After incubation,
the ﬁlters were washed and incubated for 2 h with peroxidase anti-mouse IgG. The
proteins were visualized using a chemiluminescence method (ECL). Quantiﬁcation of
proteins was performed using densitometry.
RESULTS AND DISCUSSION
Mammary tissue samples obtained from cats and dogs were homogenized, loaded
onto a SDS-polyacrylamide gel and immunoblotted with paxillin, talin, vinculin and
a-actinin antibodies. No diﬀerence in the amount of paxillin was detected for normal
and tumour tisses from cats aﬀected by breast adenoma or from dogs aﬀected by
breast chondroma. Conversely, a decrease of the amount of paxillin, as compared to
345
normal tissues of the same animal, was observed for tumour tissues from cats aﬀected
by breast solid carcinoma or from dogs aﬀected by adenocarcinoma. The decrease in
the paxillin level correlated with the grading of breast adenocarcinomas in dogs
(Scibelli et al., 2003).
No diﬀerence in the expression levels of the focal adhesion-associated proteins
vinculin, talin and a-actinin was detected in tumour tissues as compared to normal
tissues from the same species.
The amount of paxillin has been shown to be signiﬁcantly reduced during mitosis
of the cell cycle (Yamaguchi et al., 1997). Furthermore, low levels or absence of
paxillin expression have been demonstrated in some human lung cancers and liver
metastases (Ayaki et al., 2001). Cell motility has been shown to be reduced by paxillin
overexpression in lung cancer cell lines (Salgia et al., 1999). Metastatizing cells do not
tend to form clusters and exhibit cell-to-cell contacts which are the opposite of those
occurring in normally functioning cells. Low levels of paxillin may confer an advan-
tage in migration to cancer cells by interfering with the attachment to the extracellular
matrix, and this may involve blocking or sequestering signalling molecules, or
interfering with signal transduction from focal adhesions. Thus, the observation that
paxillin levels are reduced in malignant mammary tumours at a high grade of pro-
gression, and which are therefore more aggressive, may lead to further insights into
the role of paxillin in normal and transformed cells.
The low level of paxillin expression in invasive feline and canine mammary tumours
suggests that paxillin may represent a useful prognosticator of feline and canine breast
cancer malignancy. This ﬁnding may provide the basis for the development of new
diagnostic and therapeutic strategies in veterinary oncology.
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